首页> 美国卫生研究院文献>BMC Cancer >Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization – design and objectives of the Diagnosis Optimisation Study (DIOS)
【2h】

Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization – design and objectives of the Diagnosis Optimisation Study (DIOS)

机译:使用B分类对乳房异常进行穿刺活检评估的可靠性和有效性–诊断优化研究(DIOS)的设计和目标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe planned nationwide implementation of mammography screening 2007 in Germany will increase the occurrence of mammographically detected breast abnormalities. These abnormalities are normally evaluated by minimal invasive core biopsy. To minimize false positive and false negative histological findings, quality assurance of the pathological evaluation of the biopsies is essential. Various guidelines for quality assurance in breast cancer diagnosis recommend applying the B-classification for histopathological categorization. However, to date there are only few studies that reported results about reliability and validity of B-classification. Therefore, objectives of our study are to determine the inter- and intraobserver variability (reliability study) and construct and predictive validity (validity study) of core biopsy evaluation of breast abnormalities. This paper describes the design and objectives of the DIOS Study.
机译:背景技术计划在德国2007年在全国范围内实施乳房X线检查的计划将增加乳房X线检查发现的乳房异常的发生率。这些异常通常通过最小限度的侵入性核心活检来评估。为了使假阳性和假阴性组织学发现最小化,活检组织病理学评估的质量保证至关重要。乳腺癌诊断质量保证的各种指南建议将B分类应用于组织病理学分类。但是,迄今为止,仅有很少的研究报告了有关B分类的信度和效度的结果。因此,我们的研究目标是确定观察者之间和观察者之间的变异性(可靠性研究),以及对乳房异常进行核心活检评估的构造和预测效度(有效性研究)。本文介绍了DIOS研究的设计和目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号